CVS Health Co. (NYSE:CVS) Shares Sold by AQR Capital Management LLC

AQR Capital Management LLC trimmed its stake in shares of CVS Health Co. (NYSE:CVS - Free Report) by 34.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,667,174 shares of the pharmacy operator's stock after selling 1,386,324 shares during the quarter. AQR Capital Management LLC owned 0.21% of CVS Health worth $118,556,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. Coppell Advisory Solutions LLC raised its holdings in CVS Health by 17.3% in the fourth quarter. Coppell Advisory Solutions LLC now owns 1,282 shares of the pharmacy operator's stock valued at $56,000 after acquiring an additional 189 shares in the last quarter. EagleClaw Capital Managment LLC raised its holdings in shares of CVS Health by 3.4% in the 4th quarter. EagleClaw Capital Managment LLC now owns 6,135 shares of the pharmacy operator's stock valued at $275,000 after purchasing an additional 200 shares in the last quarter. Manchester Capital Management LLC lifted its position in shares of CVS Health by 4.8% during the 4th quarter. Manchester Capital Management LLC now owns 4,457 shares of the pharmacy operator's stock worth $200,000 after purchasing an additional 204 shares during the last quarter. Angeles Investment Advisors LLC grew its stake in shares of CVS Health by 3.7% during the fourth quarter. Angeles Investment Advisors LLC now owns 5,706 shares of the pharmacy operator's stock worth $256,000 after purchasing an additional 204 shares in the last quarter. Finally, Rogco LP raised its stake in CVS Health by 3.2% in the fourth quarter. Rogco LP now owns 6,752 shares of the pharmacy operator's stock valued at $303,000 after buying an additional 210 shares in the last quarter. Hedge funds and other institutional investors own 80.66% of the company's stock.

Insiders Place Their Bets

In other news, SVP James David Clark sold 7,513 shares of the company's stock in a transaction on Wednesday, March 5th. The shares were sold at an average price of $66.35, for a total transaction of $498,487.55. Following the transaction, the senior vice president now directly owns 8,394 shares of the company's stock, valued at $556,941.90. This represents a 47.23 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Michael F. Mahoney acquired 30,000 shares of CVS Health stock in a transaction that occurred on Tuesday, February 18th. The stock was bought at an average price of $66.70 per share, with a total value of $2,001,000.00. Following the purchase, the director now directly owns 39,356 shares of the company's stock, valued at approximately $2,625,045.20. This trade represents a 320.65 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 1.22% of the stock is currently owned by insiders.

CVS Health Stock Performance

Shares of NYSE:CVS traded down $1.96 during trading on Friday, reaching $67.49. The company had a trading volume of 14,303,584 shares, compared to its average volume of 11,558,645. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.81 and a quick ratio of 0.60. The stock's fifty day moving average price is $66.72 and its 200 day moving average price is $58.87. CVS Health Co. has a fifty-two week low of $43.56 and a fifty-two week high of $72.51. The firm has a market capitalization of $85.09 billion, a price-to-earnings ratio of 18.44, a price-to-earnings-growth ratio of 0.98 and a beta of 0.57.

CVS Health (NYSE:CVS - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The pharmacy operator reported $2.25 EPS for the quarter, topping analysts' consensus estimates of $1.62 by $0.63. The company had revenue of $94.59 billion during the quarter, compared to the consensus estimate of $93.07 billion. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. CVS Health's quarterly revenue was up 7.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.31 EPS. As a group, equities research analysts predict that CVS Health Co. will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, May 1st. Shareholders of record on Tuesday, April 22nd were issued a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 3.94%. The ex-dividend date was Tuesday, April 22nd. CVS Health's dividend payout ratio is presently 72.68%.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on CVS. Morgan Stanley reiterated an "overweight" rating on shares of CVS Health in a report on Tuesday, April 15th. Piper Sandler increased their price target on shares of CVS Health from $72.00 to $74.00 and gave the company an "overweight" rating in a research note on Friday, March 21st. UBS Group boosted their price objective on shares of CVS Health from $67.00 to $71.00 and gave the stock a "neutral" rating in a research report on Friday. Wells Fargo & Company increased their target price on shares of CVS Health from $68.00 to $73.00 and gave the company an "overweight" rating in a research report on Thursday, February 13th. Finally, Wolfe Research boosted their price target on shares of CVS Health from 67.00 to 70.00 and gave the company an "overweight" rating in a research report on Tuesday, February 11th. Four research analysts have rated the stock with a hold rating, sixteen have issued a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $72.69.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.